Target molecule Corp.

Target molecule Corp.

企业认证

公司成立时间 2015/7/28 0:00:00

注册资本 200000美金

员工人数 1-10人

年营业额 ￥ 100万以内

经营模式 贸易,工厂,试剂,定制,服务

主营行业 中间体,天然产物,化学试剂,癌症研究,生物活性小分子

主营产品 Inhibitors,Libraries，Natural Compounds

经营范围 TargetMol is headquartered in Boston, Massachusetts, the heart of the US Life Sciences industry. Whether they are working at a leading University or a rapidly growing startup, scientists pay careful attention to drug approved compounds. In the past, in order to speed the process of new drug discovery or cell inducement experiments, companies and institutions researched approved drugs. However, this type of drug collection is not only a waste of money, but it is also quite time consuming. TargetMol is built to help customers find their target compounds, in one stop, at a low cost. TargetMol's core product is our Approved Drug Collection, which includes 2,000 compounds. Using our Approved Drug Collection as a basis, we have developed a Natural Product Collection, a Drug Metabolism & Impurity Collection, and a Human Endogenous Compounds Library. Each TargetMol compound is offered in 1mg powder, 5mg powder, and 10M concentration solution with DMSO. Also, our molecular inhibitors can be used for cell signal transduction experiments, cell inducing experiments, new usage of old drugs, and positive control experiments.